Skip to main content
. Author manuscript; available in PMC: 2020 Oct 15.
Published in final edited form as: Int J Cancer. 2012 Sep 28;132(8):1771–1780. doi: 10.1002/ijc.27798

Figure 3.

Figure 3.

Hypermethylation of SFRP2 in prostate cancer. (a) Quantitative methylation analysis of SFRP2 in prostate. Values diagrammed at 0.01 represent zero methylation. (b) Association of SFRP2 methylation by clinicopathologic factors. M indicates number of samples that showed SFRP2 methylation within each clinicopathologic group.